This episode features Molly Gamble, Vice President of Editorial at Becker’s Healthcare. Here, she discusses leadership changes in major health systems, the HSS shifting costs from COVID-19 vaccines, treatments, & tests to the commercial market, pharmaceutical giants slamming Medicare drug price negotiations, and more.
No transcript available.
POWERED BY BLUBRRY
